Biologic therapy removes the protein molecules being
secreted by the macrophages.
Not exact matches
DHCA reduces interleukin 6 (IL - 6), a pro-inflammatory substance
secreted by T cells and
macrophages to stimulate immune response,
by epigenetically modulating the non-coding sequence of the IL - 6 gene.
It is known that
macrophages are an important component of the innate immunity against tumors and they are attracted
by locally
secreted chemokines [4].
The mechanism of action is based on the activation of
macrophages to defend against tumors
by direct tumor cytotoxicity and consequently they
secrete cytokines which recruit secondary immune cells, presenting antigen to T cells [5 - 7].
In the tumor microenvironment, galectin 3 is produced and
secreted by tumor cells, tumor - associated
macrophages, and exhausted T cells.
The most potent activator of ILC3s is the cytokine IL - 23 [12], which is primarily
secreted by activated
macrophages and DCs.